Ignite Creation Date:
2025-12-24 @ 11:06 PM
Ignite Modification Date:
2026-02-22 @ 9:38 AM
Study NCT ID:
NCT02136069
Status:
COMPLETED
Last Update Posted:
2021-12-03
First Post:
2014-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-24
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-23
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-15
First Submit QC Date:
None
Study First Post Date:
2014-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-18
Results First Submit QC Date:
None
Results First Post Date:
2021-08-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-01
Last Update Post Date:
2021-12-03
Last Update Post Date Type:
ACTUAL